Peptide mimotopes of Neisseria meningitidis group B capsular polysaccharide

Yonsei Med J. 2004 Aug 31;45(4):755-8. doi: 10.3349/ymj.2004.45.4.755.

Abstract

The antigenic similarity between Neisseria meningitidis group B (NMGB) capsular polysaccharide (PS) and human polysialic acid (PSA) has hampered the development of a NMGB PS-based vaccine. But the possibility of a safe vaccine based on NMGB PS has been demonstrated by the existence of the NMGB PS-associated nonautoreactive epitope, which is distinct from those present on human PSA. To obtain peptide mimotopes of NMGB PS, we used HmenB3, a protective and nonautoreactive monoclonal antibody, to screen a phage library with 12 amino acids. We obtained 23 phage clones that bound to HmenB3 but not in the presence of E. coli K1 PS [which is alpha(2-8)-linked PSA like NMGB PS]. The clones contained 3 mimotopes and differed from previously described NMGB PS mimotopes. Immunization with a synthetic peptide of one mimotope elicited anti-NMGB antibodies in BALB/c mice. These mimotopes may be useful in the development of group B meningococcal vaccines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Bacterial Vaccines / immunology*
  • Cloning, Molecular
  • Female
  • Meningococcal Infections / immunology*
  • Meningococcal Infections / prevention & control*
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • Neisseria meningitidis, Serogroup B / genetics
  • Neisseria meningitidis, Serogroup B / immunology*
  • Polysaccharides, Bacterial / genetics
  • Polysaccharides, Bacterial / immunology*

Substances

  • Bacterial Vaccines
  • Polysaccharides, Bacterial